What was ASP Isotopes Inc.'s quarterly revenue after the Renergen acquisition, and how did the acquisition impact its business segments?

ASP Isotopes Inc. reported $5.1 million in quarterly revenue following the Renergen acquisition, which drove growth through acquisitions and new business segments. The acquisition diversified the company into helium and liquefied natural gas (LNG), marking a strategic expansion beyond its core isotope business.

How did ASP Isotopes Inc.'s net loss and liquidity position change post-Renergen acquisition?

The company's net loss from continuing operations narrowed to $34.0 million, while its liquidity improved as a result of the Renergen acquisition. However, the company continues to face integration, regulatory, and financing risks associated with the transaction.

ASP Isotopes Inc. Reports $5.1M Quarterly Revenue Following Renergen Acquisition

Aug 14, 2026

ASP Isotopes Inc. reported quarterly revenue of $5.1 million and narrowed its net loss to $34.0 million following the acquisition of Renergen. The deal diversified the company into helium and LNG sectors, improving liquidity despite integration risks.

TradingView

2026-03-31

ASP Isotopes Partners with University of Bristol, Survives Class-Action Lawsuit

2026-04-11

ASP Isotopes Inc Targets Initial Commercial Shipments for Key Isotopes by 2026-2027

2026-04-12

ASP Isotopes Revenue Surge Tests Bullish Growth Narratives Against Deepening Losses

2026-04-13

ASP Isotopes Reports Q4 Revenue Surge Amid Widening Losses

2026-04-13

$333M Cash Backs ASP Isotopes' 2026 Push for First Sales